Literature DB >> 7261330

Relationships between immunogen structure and antisera specificity in the narcotic alkaloid series.

J W Findlay, R F Butz, E C Jones.   

Abstract

We report the production and comparative specificities of antisera raised to different immunogens containing codeine, morphine, and oxycodone. Antisera raised to bovine serum albumin (BSA) conjugates of codeine-6-hemisuccinate, ethylmorphine-6-hemisuccinate, or oxycodone-6-carboxymethyloxime had greatest recognition of structural changes around the piperidine ring nitrogen atom and th 14-position. N-carboxypropylnormorphine-BSA, N-carboxypropylnorcodeine-BSA, and norcodeine-BSA (directly coupled) conjugates elicited antisera that recognized structural changes at the 3- and 6-positions best, but also clearly discerned changes in the 14-substituent. Attachment of codeine to BSA via the 8-position gave a conjugate that elicited antisera with specificity characteristics similar to those of the antiserum to N-carboxypropylnorcodeine-BSA. Thus clear relationships existed between immunogen structure and antiserum specificity. The utility of these antisera was illustrated by the application of antiserum to codeine-6-hemisuccinate-BSA and solvent extraction to a study of codeine disposition in the dog. The specific antisera of N-carboxypropylnormorphine-BSA and to norcodeine-BSA were applied directly to an examination of the distribution of codeine and metabolically produced morphine in the milk and plasma of a nursing mother.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261330

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia.

Authors:  M Pravetoni; M Le Naour; T M Harmon; A M Tucker; P S Portoghese; P R Pentel
Journal:  J Pharmacol Exp Ther       Date:  2012-01-18       Impact factor: 4.030

Review 2.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

3.  Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens.

Authors:  Marco Pravetoni; Morgan Le Naour; Ashli M Tucker; Theresa M Harmon; Tara M Hawley; Philip S Portoghese; Paul R Pentel
Journal:  J Med Chem       Date:  2013-01-15       Impact factor: 7.446

4.  Comparative disposition of codeine and pholcodine in man after single oral doses.

Authors:  J W Findlay; A S Fowle; R F Butz; E C Jones; B C Weatherley; R M Welch; J Posner
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

5.  Synthesis of Potential Haptens with Morphine Skeleton and Determination of Protonation Constants.

Authors:  István Köteles; Károly Mazák; Gergő Tóth; Boglárka Tűz; Sándor Hosztafi
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

6.  Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptens.

Authors:  Eugene S Gutman; Thomas C Irvin; J Brian Morgan; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  RSC Chem Biol       Date:  2021-04-19

7.  A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.

Authors:  Oscar B Torres; Joshua F G Antoline; Fuying Li; Rashmi Jalah; Arthur E Jacobson; Kenner C Rice; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2015-12-16       Impact factor: 4.142

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.